Healthcare 2050

The healthcare industry is often said to be less prone to innovation compared to other sectors. This is due to various factors, including stringent regulations and the multitude of stakeholders involved. On the other hand, because the lifecycles of products and services are exceptionally long, it is an industry that constantly demands a long-term perspective for innovation.

In anticipating these long-term trends, a highly certain event that can be cited is global population growth and aging. By factoring in the accompanying changes in demographics and insurance systems, along with the advancement of technology and shifts in the geopolitical environment, it becomes possible to map out multiple future scenarios with a degree of certainty.

At Roland Berger, we are examining future scenarios for the healthcare industry looking toward 2050, based on these long-term macro trends. In this article, we introduce some of the insightful key trends from this analysis.

Global aging is advancing rapidly The proportion of people aged 65 and over worldwide is expected to double from 9.4% in 2020 to approximately 18.7% by 2060. Furthermore, aging is progressing not only in developed countries but also in emerging ones, making it a truly global challenge.

People will live longer, but not necessarily healthier The global average life expectancy is projected to increase from 73.7 years in 2022 to 78.3 years by 2050 (+4.6 years). However, the increase in healthy life expectancy will not be as significant, rising only slightly from 63.7 years (in 2022) to 66.8 years by 2050 (+3.1 years).

Diseases common among the elderly, such as frailty and Alzheimer's, threaten healthy lifespan By 2050, in addition to conditions like heart disease, stroke, and diabetes, our ability to live independently will be compromised by lifestyle-related diseases and conditions prevalent in the elderly, such as musculoskeletal disorders, Alzheimer's disease, and chronic kidney failure.

The social implementation of new technologies, such as regenerative medicine, will advance to provide solutions for the negative impacts of chronic diseases As chronic kidney failure increases, the medical costs associated with artificial dialysis will become a massive social burden. While renal organoids are currently only practically applied for purposes like drug evaluation as of 2025, they are expected to overcome technical challenges—such as vascularization and urine excretion pathways—by 2050. They will evolve to function as biological dialysis devices and eventually serve as an alternative to kidney transplants, acting as a trump card to solve the social issues surrounding chronic kidney failure.

Facing an era of unprecedented complexity and uncertainty, discussing "what the future holds" is extremely difficult. Some argue that predicting the future itself is meaningless, and that what is needed instead are strategies and organizations capable of adapting to an unpredictable future. However, compared to other industries, the healthcare sector seems relatively easier when it comes to forecasting the long-term future. To begin with, the life sciences possess an extremely long lifecycle from the birth of a technology to its practical application. Moreover, even when a technology reaches the practical stage, its implementation into society requires clearing hurdles such as regulatory frameworks, insurance reimbursement, the structure of the medical field, and acceptance by patients and society. This implies that the technologies destined to be implemented in society in 2050 have very likely already been born today. If scenarios can be formulated based on currently emerging technologies and what the society and economy of 2050 will demand from healthcare, it should be possible to make reasonably meaningful predictions.

The four statements at the beginning of this article are a fraction of the many social change predictions that serve as a foundation for building these scenarios. Aging will advance worldwide, and average life expectancy will stretch close to 80 years. Conversely, for 11 of those years, individuals will suffer from musculoskeletal diseases, Alzheimer's, and chronic kidney failure, unable to maintain good health. While medical expenses will surge, the working population supporting these elderly individuals will decline.

The probability of these social changes occurring seems high. If so, scenarios like the following can be envisioned for the future of healthcare:

1. Medical expenditures will shift toward early intervention at the pre-disease stage, targeting conditions such as locomotive syndrome, mild cognitive impairment, and obesity. 2. To protect the invaluable working population, companies will actively support employees regarding diseases prominent in the workforce, such as mental health issues. 3. Fertility treatments will be incorporated into the government budgets of most countries. 4. The adoption of renal organoids as an alternative treatment to dialysis will contribute to controlling medical costs.

The above is just a portion of the healthcare future predicted by Roland Berger. Our firm has created 11 scenarios by placing the evolution of science and technology at the foundation, and evaluating their potential for social implementation through social, economic, and political trends. Changes in demographics and disease structures are a given, but it is also predicted that healthcare funding will shift from the government to the private sector, and global social issues—represented by geopolitics and ESG—will influence health policy. In this article, by depicting the image of healthcare in 2050,